{"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"groups":[{"description":"KRT-232 60 mg + KRd","id":"OG000","title":"Part A: Dose Level 1"},{"description":"KRT-232 90 mg + KRd","id":"OG001","title":"Part A: Dose Level 2"}],"populationDescription":"Data were not collected due to study termination prior to participants' assessment at the pre-specified time points.","reportingStatus":"POSTED","timeFrame":"30 days after last dose","title":"Assess KRT-232 (AMG 232) Exposure-response Relationships (PD, Toxicity, and Efficacy).","type":"SECONDARY"}